Auszug
Als Tachykardie bezeichnet man Herzfrequenzen > 100/min, dabei ist in aller Regel erst ab Frequenzen von 150/min von einer symptomatisch oder hämodynamisch relevanten Notfallsituation auszugehen. Die Differenzierung in hämodynamisch stabile oder instabile Tachykardien ist für das Vorgehen in der Akutsituation entscheidend (Abb. 4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
ACC/AHA/ESC (2003) Guidelines for the management of patients with supraventricular arrhythmias — executive summary. Eur Heart J 24:1857–1897
Camm AJ, Garratt CJ (1991) Adenosine and supraventricular tachycardia. N Engl J Med 325:1621–1629
Chen X, Borggrefe M, Martinez-Rubio A, Hief C, Haverkamp W, Hindricks G, Breithardt G (1994) Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomised study. J Cardiovasc Pharmacol 24:664–669
Jung W, Lüderitz B (1998) Empfehlungen für die präklinische Notfallmedizin. Internist 39:142–151
Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T (1999) Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341:871–878
Manz M, Mletzko R, Jung W, Lüderitz B (1992) Electrophysiological and hemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia. Eur Heart J 13:1123–1128
Nolan JP, Deakin CD, Soar J, Bottiger BW, Smith G (2005) European Resuscitation Council. European Resuscitation Council guidelines for resuscitation. Section 4. Adult advanced life support. Resuscitation 67:39–86
Olshausen K von (2005) EKG-Information, 8. Aufl. Steinkopff, Darmstadt
Weiterführende Literatur
ACC/AHA/ESC (2003) Guidelines for the management of patients with supraventricular arrhythmias — executive summary. Eur Heart J 24:1857–1897
Brady PA, Low PA, Shen WK (2005) Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes. PACE 28:1112–1121
Chiale PA, Garro HA, Schmidberg J, Sánchez RA, Acunzo RS, Lago M, Levy G, Levin M (2006) Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac β adrenergic receptors. Heart Rhythm 3:1182–1186
Shen WK (2005) How to manage patients with inappropriate sinus tachycardia. Heart Rhythm 2/9:1015–1019
Still AM, Raatikainen P, Ylitalo A, Kauma H, Ikäheimo M, Kesäniemi A, Huikuri HV (2005) Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace 7:104–112
Weiterführende Literatur
ACC/AHA/ESC (2003) Guidelines for the management of patients with supraventricular arrhythmias — executive summary. Eur Heart J 24:1857–1897
Hsieh MH, Chen SA (2002) Catheter ablation of focal AT. In: Zipes DP, Haissaguerre M (eds) Catheter ablation of arrhythmias. Futura Publishing Co, Armonk, NY, pp 185–204
Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, Morton JB, Sparks PB, Kalman JM (2006) P wave morphology in focal atrial tachycardia. J Am Coll Cardiol 48:1010–1017
Literatur
Kistler PM, Fynn SP (2005) Focal atrial tachycardia from the ostium for the coronary sinus: electrocardiographic and electrophysiological characterization and radiofrequency ablation. J Am Coll Cardiol 45:1488–1493
Ouyang F, Ma J, Ho SY, et al (2006) Focal atrial tachycardia originating from the non-coronary aortic sinus. J Am Coll Cardiol 48:122–131
Weiterführende Literatur
ACC/AHA/ESC (2003) Guidelines for the management of patients with supraventricular arrhythmias — executive summary. Eur Heart J 24:1857–1897
Da Costa A, Thévenin J, Roche F, Romeyer-Bouchard C, Abdellaoui L, Messier M, Denis L, Faure E, Gonthier R, Kruszynski G, Pages M, Bonijoly S, Lamaison D, Defaye P, Barthélemy C, Gouttard T, Isaaz K (2006) Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) Trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation 114:1676–1681
Lukac P, Pedersen AK, Mortensen PT, Jensen HK, Hjortdal V, Hansen PS (2005) Ablation of atrial tachycardia after surgery for congenital and acquired heart disease using an electroanatomic mapping system: which circuits to expect in which substrate? Heart Rhythm 2:64–72
Magnin-Poull I, De Chillou C, Miljoen H, Andronache M, Aliot E (2005) Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects. J Cardiovasc Electrophysiol 16:688–689
Weiterführende Literatur
Fuster V et al. (2006) ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation — executive summary. Eur Heart J 27:1979–2030
Weiterführende Literatur
ACC/AHA/ESC (2003) Guidelines for the management of patients with supraventricular arrhythmias — executive summary. Eur Heart J 24:1857–1897
Pasquie JL, Scalzi J, Macia JC, et al (2006) Long-term safety and efficacy of slow pathway ablation in patients with atrioventricular nodal re-entrant tachycardia and preexisting prolonged PR interval. Europace 8:129–133
Scheinman MM, Huang S (2000) The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 23:1020–1028
Literatur
Delacrétaz E (2006) Clinical practice. Supraventricular tachycardia. N Engl J Med 354:1039–1051
Lerman BB, Basson CT (2003) High-risk patients with ventricular preexcitation — a pendulum in motion. N Engl J Med 349:1787–1789
Morady F (1999) Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 340:534–544
Weiterführende Literatur
ACC/AHA/ESC (2003) Guidelines for the management of patients with supraventricular arrhythmias — executive summary. Eur Heart J 24:1857–1897
Literatur
Jung W, Andresen D, Block M, Böcker D, Hohnloser SH, Kuck KH, Sperzel J (2006) Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95:696–708
Lewalter T, Schwab JO, Nickenig G (2006) Ventrikuläre Tachykardien. Diagnostisches Spektrum und therapeutische Möglichkeiten. Internist 47:1001–1012
Weiterführende Literatur
Zipes DP et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 27:2099–2140
Weiterführende Literatur
Paul M, Schulze-Bahr E, Eckardt L, Breithardt G, Wichter T (2005) Rechtsventrikuläre Tachyarrhythmien — Diagnostik und Therapie. Herzschr Elektrophys 16:260–269
Kiès P, Bootsma M, Bax J, Schalij MJ, van der Wall EE (2006) Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Screening, diagnosis, and treatment. Heart Rhythm, pp 225–234
Literatur
Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005) Brugada Syndrome. Report of the Second Consensus Conference. Heart Rhythm 2/4:429–440
Literatur
Committee for Proprietary Medicinal Products (ed) (1997) Points to Consider: The Assessment of the Potential for QT Interval Prolongation by Non-Cardiovascular Medicinal Products. The European Agency for the Evaluation of Medicinal Products
Moss AJ, Kass (2005) Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 115:2018–2024
Moss AJ, Windle JR, Hall WJ, et al (2005) Safety and efficacy of flecainide in subjects with long QT-3 syndrome (DeltaKPQmutation): a randomised, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol 10:59–66
Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J (2004) Association of long QT syndrome loci and cardiac events among patients treated with β-blockers. JAMA 292: 1341–1344
Roberts R (2006) Genomics and cardiac arrhythmias. J Am Coll Cardiol 47:9–21
Schwartz PJ, Vincent GM, Moss AF, Crampton RS (1993) Diagnostic criteria for the long QT syndrome — an update. Circulation 88:782–784
Shimlizu W, Aiba T, Antzelevitch C (2005) Specific therapy based on the genotype and cellular mechanisms in inherited cardiac arrhythmias. Long QT syndrome and Bru-gada syndrome. Curr Pharm Des 11:1561–1572
Wolpert C, Schimpf R, Giustetto C, et al (2005) Further insights into the effect of qui-nidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electro-physiol 16:54–58
Weiterführende Literatur
Ito S, Tada H, Naito S, et al (2003) Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventricular outflow tract tachycardia. J Cardiovasc Electrophysiol 14:1260–1286
Joshi S, Wilber DJ (2005) Ablation of idiopathic right ventricular outflow tract tachycardia: current perspective. J Cardiovasc Electrophysiol 16(suppl 1):S52–58
Kurzidim K, Neumann T, Vukajlovic D, et al (2002) Gekühlte HF-Stromkatheterablation epikardialer Ausflusstrakttachykardien über die sinus valsalvae der Aorta. Z Kardiol 91:796–805
Quyang F, Fotuhi P, Ho SY, et al (2002) Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp. J Am Coll Cardiol 39:500–508
Shimoike E, Ohnishi Y, Ueda N, et al (1999) Radiofrequency catheter ablation of the left ventricular outflow tachycardia from the coronary cusp: a new approach to the tachycardia focus. J Cardiovasc Electrophysiol 10:1005–1009
Tanner H, Wolber T, Schwick N, et al (2005) Electrocardiographic pattern as a guide for management and radiofrequency ablation of idiopathic ventricular tachycardia. Cardiology 103:30–36
Rights and permissions
Copyright information
© 2007 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
(2007). Differentialtherapie: vom EKG zur Behandlung. In: Tachykarde Arrhythmien. Steinkopff. https://doi.org/10.1007/978-3-7985-1752-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1752-3_4
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1524-6
Online ISBN: 978-3-7985-1752-3
eBook Packages: Medicine (German Language)